Prepandemic influenza vaccine H5N1 (split virion, inactivated, adjuvanted; Prepandrix™): a guide to its use as an active immunization against influenza A subtype H5N1 virus

Author： Adis International Limited  

Publisher： Adis International

ISSN： 1172-0360

Source： Drugs & Therapy Perspectives, Vol.25, Iss.3, 2009-03, pp. : 5-9

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

A/H5N1 Prepandemic Influenza Vaccine (Whole Virion, Vero Cell-Derived, Inactivated) [Vepacel®]

By Plosker Greg L.  

Drugs, Vol. 72, Iss. 11, 2012-07 ,pp. : 1543-1557

Adis International

Access to resources Recommend Favorite

M59-adjuvanted vaccine against H5N1 influenza antigenic in volunteers

By  

Inpharma, Vol. 1, Iss. 1293, 2001-01 ,pp. : 10-10

Adis International

Access to resources Recommend Favorite

An influenza A H5N1 virus vaccine elicits a protective response, even without an adjuvant and against divergent H5N1 strains

By  

Inpharma, Vol. 1, Iss. 1582, 2007-01 ,pp. : 8-8

Adis International

Access to resources Recommend Favorite

Adjuvanted H5N1 influenza vaccine offers good safety profile

By  

Inpharma, Vol. 1, Iss. 1608, 2007-01 ,pp. : 10-10

Adis International

Access to resources Recommend Favorite

Influenza A virus vaccine H1N1: Lack of efficacy in influenza A virus H1N1 subtype: case report

By  

Reactions Weekly, Vol. 1, Iss. 1341, 2011-01 ,pp. : 19-20

Adis International

Access to resources Recommend Favorite